Neuromeka Co., Ltd. (KOSDAQ:348340)
South Korea · Delayed Price · Currency is KRW 57,100
-100 (-0.17%)
Apr 10, 2026, 3:30 PM KST
Neuromeka Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 18,954 | 25,269 | 13,743 | 9,755 | 7,351 |
Other Revenue | - | - | - | - | -0 |
| 18,954 | 25,269 | 13,743 | 9,755 | 7,351 | |
Revenue Growth (YoY) | -24.99% | 83.87% | 40.89% | 32.69% | 80.81% |
Cost of Revenue | 15,634 | 21,209 | 12,580 | 8,672 | 5,555 |
Gross Profit | 3,320 | 4,061 | 1,163 | 1,083 | 1,797 |
Selling, General & Admin | 10,757 | 11,597 | 8,285 | 6,211 | 2,935 |
Research & Development | 5,424 | 6,620 | 5,264 | 1,923 | 931.67 |
Amortization of Goodwill & Intangibles | 112.93 | 118.84 | 106.04 | 88.85 | 38.31 |
Other Operating Expenses | 502.96 | 485.04 | 253.64 | 242.51 | 123.31 |
Operating Expenses | 18,177 | 23,499 | 15,989 | 8,892 | 4,806 |
Operating Income | -14,857 | -19,439 | -14,825 | -7,809 | -3,009 |
Interest Expense | -5,290 | -4,929 | -2,050 | -292 | -532.95 |
Interest & Investment Income | 480.21 | 626.1 | 1,097 | 315.7 | 57.4 |
Earnings From Equity Investments | -424.45 | 24.55 | -27.31 | - | - |
Currency Exchange Gain (Loss) | -18.14 | 24.66 | 99.84 | 72.27 | 115.2 |
Other Non Operating Income (Expenses) | -2,247 | 6,472 | -2,150 | -487.07 | -3,201 |
EBT Excluding Unusual Items | -22,356 | -17,221 | -17,856 | -8,201 | -6,570 |
Gain (Loss) on Sale of Investments | - | 494.01 | 282.13 | - | - |
Gain (Loss) on Sale of Assets | -124.52 | 2.36 | -72.2 | - | -23.88 |
Other Unusual Items | 555.57 | - | - | - | - |
Pretax Income | -21,925 | -16,724 | -17,646 | -8,201 | -6,594 |
Income Tax Expense | 66.31 | 30.57 | 7.1 | - | - |
Earnings From Continuing Operations | -21,991 | -16,755 | -17,654 | -8,201 | -6,594 |
Minority Interest in Earnings | 18.08 | - | - | - | - |
Net Income | -21,973 | -16,755 | -17,654 | -8,201 | -6,594 |
Net Income to Common | -21,973 | -16,755 | -17,654 | -8,201 | -6,594 |
Shares Outstanding (Basic) | 11 | 11 | 10 | 9 | 7 |
Shares Outstanding (Diluted) | 11 | 11 | 10 | 9 | 7 |
Shares Change (YoY) | 6.54% | 1.17% | 21.12% | 19.56% | 440.13% |
EPS (Basic) | -1956.00 | -1589.00 | -1693.82 | -953.00 | -916.23 |
EPS (Diluted) | -1956.00 | -1589.00 | -1694.00 | -953.00 | -916.23 |
Free Cash Flow | -14,511 | -35,625 | -42,925 | -11,008 | -1,267 |
Free Cash Flow Per Share | -1291.76 | -3378.64 | -4118.56 | -1279.29 | -175.97 |
Gross Margin | 17.52% | 16.07% | 8.46% | 11.10% | 24.44% |
Operating Margin | -78.38% | -76.93% | -107.88% | -80.06% | -40.93% |
Profit Margin | -115.93% | -66.30% | -128.46% | -84.07% | -89.70% |
Free Cash Flow Margin | -76.56% | -140.98% | -312.34% | -112.85% | -17.23% |
EBITDA | -12,025 | -17,117 | -13,819 | -6,908 | -2,120 |
EBITDA Margin | -63.44% | -67.74% | -100.55% | -70.82% | -28.84% |
D&A For EBITDA | 2,832 | 2,322 | 1,007 | 901.29 | 888.92 |
EBIT | -14,857 | -19,439 | -14,825 | -7,809 | -3,009 |
EBIT Margin | -78.38% | -76.93% | -107.88% | -80.06% | -40.93% |
Advertising Expenses | 357.64 | 764.89 | 605.54 | 145.27 | 27.26 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.